Çakıcı Kerimcan, Gökdoğan Ozan, Genç Deniz, Günaydın Burcu, Üçüncü Harun
Erciş Şehit Rıdvan Çevik State Hospital, Otolaryngology, Van, Turkey.
Mugla Sitki Kocman University, Faculty of Medicine, Otolaryngology, Mugla, Turkey.
Int J Pediatr Otorhinolaryngol. 2023 Nov;174:111740. doi: 10.1016/j.ijporl.2023.111740. Epub 2023 Sep 19.
Recurrent tonsillitis and tonsillar hypertrophy are two common diseases in children for which tonsillectomy is the definitive solution. The underlying causes of both diseases are not fully known. The aim of this study was to identify the predominant innate lymphoid cells in both diseases of the palatine tonsils, which are known to play an important role in the immune system.
Children who underwent tonsillectomy were divided into two groups as recurrent tonsillitis and tonsillar hypertrophy according to the indication for surgery. The proportions of innate lymphoid cell (ILC) groups and IFN-gamma, IL-10 and IL-17 secreting T lymphocyte cells were determined in tonsil and blood samples obtained during surgery. Local and peripheral immune responses were evaluated. Innate immune responses and acquired immune responses were compared.
The results of our study showed that the proportions of the innate lymphoid cell 1 group (ILC1) were similar in tonsil tissue in patients with recurrent tonsillitis and tonsil hypertrophy, with no statistically significant difference. It was observed that the innate lymphoid cell 2 group (ILC2) was the predominant group in tonsil hypertrophy, the innate lymphoid cell 3 group (ILC3) was the predominant innate lymphoid cell group in recurrent tonsillitis, and the proportion of IL-17 secreting T lymphocytes in blood and tonsillar mononuclear cells was higher in recurrent tonsillitis patients than in tonsil hypertrophy patients.
With the results obtained, the predominant innate lymphoid cells in the pathogenesis of both diseases were identified and local and peripheral responses were compared. These findings may be a guide for possible medical treatments for both diseases in the future.
复发性扁桃体炎和扁桃体肥大是儿童常见的两种疾病,扁桃体切除术是其最终解决方案。这两种疾病的潜在病因尚不完全清楚。本研究的目的是确定腭扁桃体这两种疾病中主要的固有淋巴细胞,已知这些细胞在免疫系统中起重要作用。
接受扁桃体切除术的儿童根据手术指征分为复发性扁桃体炎组和扁桃体肥大组。测定手术期间采集的扁桃体和血液样本中固有淋巴细胞(ILC)亚群以及分泌干扰素-γ、白细胞介素-10和白细胞介素-17的T淋巴细胞的比例。评估局部和外周免疫反应。比较固有免疫反应和获得性免疫反应。
我们的研究结果表明,复发性扁桃体炎患者和扁桃体肥大患者扁桃体组织中固有淋巴细胞1亚群(ILC1)的比例相似,无统计学显著差异。观察到固有淋巴细胞2亚群(ILC2)是扁桃体肥大中的主要亚群,固有淋巴细胞3亚群(ILC3)是复发性扁桃体炎中主要的固有淋巴细胞亚群,复发性扁桃体炎患者血液和扁桃体单个核细胞中分泌白细胞介素-17的T淋巴细胞比例高于扁桃体肥大患者。
根据所得结果,确定了这两种疾病发病机制中的主要固有淋巴细胞,并比较了局部和外周反应。这些发现可能为未来这两种疾病的可能药物治疗提供指导。